Evidence map›Paper›PMID 34485991›Full record

ArticleAdvanced nanobiomed research2021

Engineering the Multi-Enzymatic Activity of Cerium Oxide Nanoparticle Coatings for the Antioxidant Protection of Implants.

Nicholas J Abuid, Morgan E Urdaneta, Kerim M Gattas-Asfura, Caterina Zientek, Cristina Isusi Silgo, Jose A Torres, Kevin J Otto, Cherie L Stabler

Abstract read
In one paragraph

Article in Advanced nanobiomed research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Adverse effects and underlying mechanism of rare earth elements.Environmental health : a global access science source · 2025
    Pooled it
  2. Article
  3. Article
  4. In Sickness and in Health: The Oxygen Reactive Species and the Bone.Frontiers in bioengineering and biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicholas J AbuidJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Morgan E UrdanetaJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Kerim M Gattas-AsfuraJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Caterina ZientekJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Cristina Isusi SilgoJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Jose A TorresJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Kevin J OttoJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.
Cherie L StablerJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611-7011 USA.

Funding

Functionalized, Nanoscale Coatings for Islet EncapsulationDP2DK083096 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI STABLER, CHERIE L · 2008 to 2011
$2.5M
Engineering Ultrathin Immunomodulatory Coatings for Islet EncapsulationR01DK100654 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI STABLER, CHERIE L · 2014 to 2018
$2.2M
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical EngineeringT32DK108736 · NIDDK · UNIVERSITY OF FLORIDA · PI MARK A. ATKINSON, Benjamin George Keselowsky · 2017 to 2026
$1.9M
Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet TransplantsR01DK126413 · NIDDK · UNIVERSITY OF FLORIDA · PI STABLER, CHERIE L · 2020 to 2024
$1.7M
NIDDK NIH HHS DP2 DK083096NIDDK NIH HHS R01 DK100654NIDDK NIH HHS R01 DK126413NIDDK NIH HHS T32 DK108736
6 · The paper itself

Abstract

Imbalance of oxidants is a universal contributor to the failure of implanted devices and tissues. A sustained oxidative environment leads to cytotoxicity, prolonged inflammation, and ultimately host rejection of implanted devices/grafts. The incorporation of antioxidant materials can inhibit this redox/inflammatory cycle and enhance implant efficacy. Cerium oxide nanoparticles (CONP) is a highly promising agent that exhibits potent, ubiquitous, and self-renewable antioxidant properties. Integrating CONP as surface coatings provides ease in translating antioxidant properties to various implants/grafts. Herein, we describe the formation of CONP coatings, generated via the sequential deposition of CONP and alginate, and the impact of coating properties, pH, and polymer molecular weight, on their resulting redox profile. Investigation of CONP deposition, layer formation, and coating uniformity/thickness on their resulting oxidant scavenging activity identified key parameters for customizing global antioxidant properties. Results found lower molecular weight alginates and physiological pH shift CONP activity to a higher H

Indexed as

antioxidantsbiomaterialsceriumcoatingsdiabetes

Identifiers

PMID34485991
PMCPMC8412420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.